Literature DB >> 34979888

Immunity, Vascular Aging and Stroke.

Anna-Maria Louka1, Dimitrios Sagris1, George Ntaios1.   

Abstract

Stroke is one of the most devastating manifestations of cardiovascular disease. Growing age, arterial hypertension, and atherosclerosis are identified as independent risk factors for stroke, primarily due to structural and functional alterations in the cerebrovascular tree. Recent data from in vitro and clinical studies have suggested that the immune system influences atherosclerosis, promoting vascular stiffness and vascular aging and contributing to ischemic stroke, intracranial haemorrhage and microbleeds, white matter disease, and cognitive decline. Furthermore, aging is related to a chronic low-grade inflammatory state, in which macrophage, neutrophils, natural killer (NK cells), and B and T lymphocytes act as major effectors of the immune-mediated cell responses. Moreover, oxidative stress and vascular inflammation are correlated with endothelial dysfunction, vascular aging, blood-brain barrier disruption, lacunar lesions, and neurodegenerative disorders. This review discusses the pathophysiological roles of fundamental cellular and molecular mechanisms of aging, including the complex interplay between them and innate immunity, as well as vascular dysfunction, arterial stiffness, atherosclerosis, atherothrombosis, systemic inflammation, and blood-brain barrier dysfunction. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Innate immunity; blood-brain barrier; cardiovascular risk factors; stroke; vascular aging; vascular dysfunction

Mesh:

Year:  2022        PMID: 34979888     DOI: 10.2174/0929867329666220103101700

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.740


  1 in total

1.  Lipids and atrial fibrillation: New insights into a paradox.

Authors:  Dimitrios Sagris; Stephanie L Harrison; Gregory Y H Lip
Journal:  PLoS Med       Date:  2022-08-11       Impact factor: 11.613

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.